Displaying 301 - 310 of 628
How to actively participate in you cancer care (self advocacy): 2024 Leukemia Conference
Updated:
Learn practical ways to be a proactive agent of change in your own cancer experience or that of your loved one. This webcast was led by Geoffrey Molle and Natasha Sani, from the Community Services Team at LLSC, and will include people impacted by blood cancer. They will offer…
Leukemia
The Collings Stevens Family Foundation partners with LLSC to help Canadians impacted by CML
Updated:
The Leukemia & Lymphoma Society of Canada, with partners like The Collings Stevens Family Foundation, is informing and empowering people impacted by chronic myeloid leukemia (CML), a once-fatal blood cancer now a manageable disease.
Work for LLSC
Updated:
At the Leukemia & Lymphoma Society of Canada, we are driven by our ambition to change the course of the blood cancer experience for every person in Canada. This vision is a huge undertaking requiring a culture that fosters big ideas, bold actions, and a great amount of heart.
Emotions chart for children
Updated:
A blood cancer diagnosis can be overwhelming for children. This illustrated resource is designed to help parents understand the emotions their child may be going through and is offering strategies to manage them.
Mental health and wellness
Understanding Graft vs Host Disease (GvHD)
Updated:
GvHD is a serious health complication that can result from an allogeneic stem cell transplant. It can happen when donor cells (graft) mistakenly attack the transplant recipient’s (host) tissue and cells.
Treatment and side effects
Treating Graft-versus-Host Disease (GvHD)
Updated:
There are various treatments, depending on whether you have acute or chronic GvHD. Acute GvHD which usually develops within 100 days of an allogeneic stem cell transplant, and chronic GvHD (cGvHD), which develops more than 100 days after the transplant.
Treatment and side effects
Caring for your skin, nails, hair and mouth
Updated:
Learn how to care for skin, nails, hair, and mouth during and after cancer treatments.
Treatment and side effects
New AI research award recipient supported by UFCW
Updated:
One of the exciting, novel aspects of LLSC’s latest blood cancer research awards is the introduction of the Artificial Intelligence (AI) Catalyst Grant, for the application of AI to blood cancer research.
Kent
Updated:
After getting a stem cell transplant, and another week of chemo for CLL that Kent was diagnosed with at age 42 in 2006, one of the lingering effects was chemo induced cognitive impairment, sometimes referred to as “brain fog.” It caused his short-term memory issues and he began…